Similar articles

• ESA therapy for anemia management: a call for civil discourse.

  McAllister CJ. McAllister CJ. Nephrol News Issues. 2007 Jun;21(7):49-50. Nephrol News Issues. 2007. PMID: 17623986 No abstract available.
• [Anemia in chronic renal failure and erythropoietin].

  Rosenlöf K. Rosenlöf K. Duodecim. 1995;111(15):1489-95. Duodecim. 1995. PMID: 9244705 Review. Finnish. No abstract available.
• Target hemoglobin level for EPO therapy in CKD.

  Parfrey PS. Parfrey PS. Am J Kidney Dis. 2006 Jan;47(1):171-3. doi: 10.1053/j.ajkd.2005.11.001. Am J Kidney Dis. 2006. PMID: 16377399 No abstract available.
• Managing anemia. What do we do now? Views from Canada.

  Mendelssohn DC, Muirhead N, Manns BJ. Mendelssohn DC, et al. Nephrol News Issues. 2007 Jun;21(7):55-7. Nephrol News Issues. 2007. PMID: 17623988 No abstract available.
• Recombinant human erythropoietins, biosimilars and immunogenicity.

  Schellekens H. Schellekens H. J Nephrol. 2008 Jul-Aug;21(4):497-502. J Nephrol. 2008. PMID: 18651538 Review.